This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
F-18 fluoroestradiol (FES)-PETscans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PETscans.
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, the average number of PETscans per fixed PET site (versus mobile PET) increased 6.7%
F-18 florbetaben PETscans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PETimaging in clinical settings,” the group wrote.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PETscans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
An AI algorithm designed for brain PETimaging found a glioblastoma in a patient that had gone undetected by physicians, according to a case reported February 15 in the Journal of NuclearMedicine. Baseline scan (A), segmentation results (B), and follow-up scan (C) from patient with molecular glioblastoma.
Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PETscan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PETscans will now be made by local Medicare Administrative Contractors (MACs).
TORONTO -- AuntMinnie.com spoke with prostate cancer imaging expert Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, at the Society of NuclearMedicine and Molecular Imaging annual meeting about new developments in PET/CT imaging in patients on Lu-177 PSMA-617 therapy.
PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with high-efficacy disease-modifying therapies, according to a recent study by researchers in Boston. The researchers performed F-18 PBR06 PETscans on 22 patients with MS and eight healthy controls.
A PET radiotracer for diagnosing Alzheimer’s disease may also be used to measure vascular brain changes in patients during PET/MRI scans, according to a study published December 7 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
PETimaging shows different brain activity in people taking methadone or buprenorphine for opioid use disorder (OUD), according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging annual meeting. Image and caption courtesy of Jacob Dubroff, MD, PhD.
FAPI-PETimaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of NuclearMedicine. A) Maximum-intensity-projection PETimages.
Theranostics pairs diagnostic biomarkers that can be visualized on nuclearmedicineimaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.
A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PETscans, according to a study published October 13 in Medical Hypotheses. “We A) PETscan of a healthy subject. (B) B) PETscan of a long COVID patient.
Gallium-68 (Ga-68) fibroblast activation protein inhibitor (FAPI) PET/CT is a promising new method for imaging gastric cancer, according to a study published January 16 in the Journal of Cancer Research and Clinical Oncology. indicating tracer accumulation on PET (arrowhead, d). The maximum projection image of PET (e).
Two experts review SNMMI (Society of NuclearMedicine and Molecular Imaging) guidelines for use of PSMA PETscans in prostate cancer detection, as well as awareness about this new modality within the patient community.
PETimaging using a newly developed radiotracer has identified different patterns of brain tau pathology over time in early-onset versus late-onset Alzheimer’s disease patients, according to a study published February 1 in the Journal of NuclearMedicine. in 15 patients with negative amyloid PETscans; 1.18 in
PET/CT imaging with a new radiotracer (F-18 PSMA-1007) is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer, according to a study published on July 1 in JAMA Oncology. Out of 150 men who participated, 134 ultimately underwent radical prostatectomies (the mean age was 62 years old).
Clinical brain imaging with a newly developed portable PET scanner appears feasible, with a comparison to conventional PETimaging for the first time revealing similar results in human subjects, according to a group in New York City. The study was published on December 14 in the Journal of NuclearMedicine.
Dynamic PETscans acquired in half the time of normal scans appear clinically feasible for patients with lung lesions, according to nuclearmedicine researchers in Shenzhen, China. In addition, PET/CT scan showed many FDG-avid lung nodules in the mediastinum. (A, Image courtesy of EJNMMI Physics.
The findings were published in Clinical NuclearMedicine. The team developed a technique called F18 PBR 06 PETimaging. The newly published study involved performing PETscans on 22 people with MS and eight healthy controls. It involves the injection of a tracer, or dye, that binds to the microglia cells.
Scans processed with the algorithm can also provide additional details by using an overlay of an MRI or CT image of the same region, the company said. More than 500,000 PETscans are performed per year in India, with demand for nuclearmedicine growing, Claritas noted.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PETscans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
The following is the list of candidates for the 2024 edition of the Minnies, AuntMinnie.com 's campaign to recognize the best and brightest in medical imaging. Image from Martin W. tesla brain MRI scans. Image from Denis Le Bihan, PhD, of the NeuroSpin research facility, et al. AI detects cancer on breast MRI.
An international survey of treatment centers has revealed significant differences in several aspects of Lu-177 PSMA-617 prostate cancer therapy, including patient imaging protocols, according to a study published January 18 in the Journal of NuclearMedicine. In addition, different PET radiotracers are used.
A new artificial intelligence tool provides a fully automated, easy-to-use and objective way to detect and evaluate brain tumors, according to new research published in the October issue of the Journal of NuclearMedicine.
30, 2025 Earlier this month, the Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PETimaging in patients with mild cognitive impairment, Alzheimers disease and other dementias.
The promise of imaging One challenge is that advances in Alzheimer’s care can only help people if they are reaching the right patients at the right time in their patient journey. Reimbursement barriers Unfortunately, until recently, there were significant barriers to receiving amyloid PETimaging in some regions.
Theranostics pairs diagnostic biomarkers that can be visualized on nuclearmedicineimaging with therapeutic agents that share a specific target in diseased cells or tissues. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent. It's full-spectrum, personalized care," Vroman told AuntMinnie.com.
Researchers have found biomarkers that enable doctors to reliably distinguish the two conditions—albeit only with data from a particular imaging technique called positron emission tomography (PET).
Theranostics is increasingly being used to image and treat prostate cancer and neuroendocrine tumors. Several presenters at the Society for NuclearMedicine and Molecular Imaging's (SNMMI) 2024 meeting in Toronto shared new findings in women's studies. Women's theranostics appears to already be on the horizon.
A new PETscan has shown promise in reliably detecting benign tumors in the pancreas that cannot be detected by various imaging techniques such as CT, MRI, and PETscans.
mtaschetta-millane Sat, 06/24/2023 - 15:00 June 24, 2023 — A newly developed technology called “augmented whole-body scanning via magnifying PET” ( AWSM-PET ) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging. Louis, Missouri.
milla1cf Wed, 05/31/2023 - 20:52 May 31, 2023 — GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning-based image processing software included in GE HealthCare’s growing Effortless Recon DL portfolio. Gallen in Switzerland [vii].
milla1cf Fri, 02/09/2024 - 09:17 February 9, 2024 — A novel PETimaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of NuclearMedicine.
How Do PET/CT Scans Work? PET and CT scans are two imaging processes that help doctors learn the location and metabolism of cancer cells in order to make proper diagnosis and treatment plans. Positron Emission Tomography (a PETscan) uses nuclearmedicine to detect metabolic signals emitted by cancer cells.
This research was presented at the Society of NuclearMedicine and Molecular Imaging 2023 Annual Meeting. “Up Unlike other PET scanners, the UHR scanner features truly pixelated detectors and reaches a 1.25 Unlike other PET scanners, the UHR scanner features truly pixelated detectors and reaches a 1.25
The study will also then help identify early response to immunotherapies, using sequential whole-body imaging to monitor CD8 changes over time, enabling physicians to switch patients who are not responding to alternative treatment options sooner. Molecular Imaging and Biology, 20(5), 696–704. Lancet Oncology 2023; 24(3): e133-e143.
While it forms in the tissues surrounding your body’s internal organs, location influences the symptoms and subsequent diagnostic procedures, which include imaging and imaging-guided biopsy. Imaging for Mesothelioma Medical imaging serves several purposes.
Brain Tumor Spotted on PETImaging An AI algorithm named “JuST_BrainPET” identified a glioblastoma in a patient that had been missed by physicians. This finding, reported in the Journal of NuclearMedicine, underscores the potential of AI-based decision support in diagnostic and treatment planning.
PACS – Picture Archiving and Communication System; a system involved in acquiring the medical images, transmission, viewing, storage, and retrieval of same images. The fundamental parts of PACS are – imaging acquisition, display workstations, archive servers. of imaging modalities, storage space, no.
Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically. The post Breakthroughs in Positron Emission Tomography Imaging appeared first on Open MedScience.
Radiopharmaceuticals in diagnostics provide critical insights into disease processes, improving accuracy, patient care, and treatment outcomes significantly. The post The Transformative Power of Radiopharmaceuticals in Diagnostics appeared first on Open MedScience.
DICOM Image Format is an international standard to transmit, store, retrieve, print, process, and display medical imaging information. DICOM allows transmitting medical imaging data to devices like scanners, servers, workstations, printers, network hardware, and PACS. What is DICOM Image Format?
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content